SYN-TECH Chem. & Pharm. Co., Ltd.

1777

TW0001777001

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
84.6 ^TWD	+2.92%		+3.55%	-0.70%

Mar. 08	SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Syn-Tech Chem. & Pharm. Co., Ltd. Announces Internal Audit Officer Changes

May 04, 2021 at 01:28 am EDT

Syn-Tech Chem. & Pharm. Co., Ltd. appointed CHANG,CHING-YUN as Internal Audit Officer in place of HUANG,SHIH-MING with effect from May 4, 2021.

Latest news about SYN-TECH Chem. & Pharm. Co., Ltd.

SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Approves Cash Dividend, Payable on August 18, 2023	23-06-20	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Appointment of Corporate Governance Officer	22-12-29	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Operating Revenue Results for the Month and Nine Months Ended September 30, 2022	22-11-01	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Executive Changes	22-08-01	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Change of Research and Development Officer	22-07-01	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Cash Dividend, Payable on August 19, 2022	22-06-21	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-08	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-03	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Declares Cash Dividend Payable on October 7, 2021	21-09-01	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Election of Chen-Ming, Hsiao as Chairman	21-08-24	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Appointment of Members of Audit Committee	21-08-24	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Change of Members of Remuneration Committee	21-08-24	CI
SYN-TECH Chem. & Pharm. Co., Ltd. Announces Change of Directors	21-08-24	CI
Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-04	CI
Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-04	CI
Syn-Tech Chem. & Pharm. Co., Ltd. Announces Internal Audit Officer Changes	21-05-04	CI
Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-16	CI

Chart SYN-TECH Chem. & Pharm. Co., Ltd.

Duration

Period

More charts

SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.

Sector

Pharmaceuticals

Calendar

2024-04-30 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SYN-TECH CHEM. & PHARM. CO., LTD.	-0.70%	116M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals